These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23267058)

  • 1. Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.
    Hedlund EM; Yang X; Zhang Y; Yang Y; Shibuya M; Zhong W; Sun B; Liu Y; Hosaka K; Cao Y
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):654-9. PubMed ID: 23267058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.
    Yang X; Zhang Y; Yang Y; Lim S; Cao Z; Rak J; Cao Y
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13932-7. PubMed ID: 23918367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
    Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
    Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
    Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental growth factor upregulation is a host response to antiangiogenic therapy.
    Bagley RG; Ren Y; Weber W; Yao M; Kurtzberg L; Pinckney J; Bangari D; Nguyen C; Brondyk W; Kaplan J; Teicher BA
    Clin Cancer Res; 2011 Mar; 17(5):976-88. PubMed ID: 21343374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-Grab Enhances the Efficacy of Radiation Therapy by Blocking VEGF-A and Treatment-Induced PlGF.
    Park I; Yang H; Park JS; Koh GY; Choi EK
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):609-618. PubMed ID: 30017791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PlGF blockade does not inhibit angiogenesis during primary tumor growth.
    Bais C; Wu X; Yao J; Yang S; Crawford Y; McCutcheon K; Tan C; Kolumam G; Vernes JM; Eastham-Anderson J; Haughney P; Kowanetz M; Hagenbeek T; Kasman I; Reslan HB; Ross J; Van Bruggen N; Carano RA; Meng YJ; Hongo JA; Stephan JP; Shibuya M; Ferrara N
    Cell; 2010 Apr; 141(1):166-77. PubMed ID: 20371352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
    Eriksson A; Cao R; Pawliuk R; Berg SM; Tsang M; Zhou D; Fleet C; Tritsaris K; Dissing S; Leboulch P; Cao Y
    Cancer Cell; 2002 Feb; 1(1):99-108. PubMed ID: 12086892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.
    Malik AK; Baldwin ME; Peale F; Fuh G; Liang WC; Lowman H; Meng G; Ferrara N; Gerber HP
    Blood; 2006 Jan; 107(2):550-7. PubMed ID: 16189273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human choriocarcinomas: placental growth factor-dependent preclinical tumor models.
    Bagley RG; Ren Y; Kurtzberg L; Weber W; Bangari D; Brondyk W; Teicher BA
    Int J Oncol; 2012 Feb; 40(2):479-86. PubMed ID: 22075622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.
    Graziani G; Ruffini F; Tentori L; Scimeca M; Dorio AS; Atzori MG; Failla CM; Morea V; Bonanno E; D'Atri S; Lacal PM
    Oncotarget; 2016 Nov; 7(45):72868-72885. PubMed ID: 27655684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.
    Rakic JM; Lambert V; Devy L; Luttun A; Carmeliet P; Claes C; Nguyen L; Foidart JM; Noël A; Munaut C
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3186-93. PubMed ID: 12824270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGFR-2-mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes.
    Freitas-Andrade M; Carmeliet P; Stanimirovic DB; Moreno M
    J Neurochem; 2008 Nov; 107(3):756-67. PubMed ID: 18786179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells.
    Hwang JE; Lee JH; Park MR; Kim DE; Bae WK; Shim HJ; Cho SH; Chung IJ
    Yonsei Med J; 2013 Mar; 54(2):374-80. PubMed ID: 23364970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.
    Schomber T; Kopfstein L; Djonov V; Albrecht I; Baeriswyl V; Strittmatter K; Christofori G
    Cancer Res; 2007 Nov; 67(22):10840-8. PubMed ID: 18006829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sFLT01: a novel fusion protein with antiangiogenic activity.
    Bagley RG; Kurtzberg L; Weber W; Nguyen TH; Roth S; Krumbholz R; Yao M; Richards B; Zhang M; Pechan P; Schmid S; Scaria A; Kaplan J; Teicher BA
    Mol Cancer Ther; 2011 Mar; 10(3):404-15. PubMed ID: 21252283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity.
    Incio J; Tam J; Rahbari NN; Suboj P; McManus DT; Chin SM; Vardam TD; Batista A; Babykutty S; Jung K; Khachatryan A; Hato T; Ligibel JA; Krop IE; Puchner SB; Schlett CL; Hoffmman U; Ancukiewicz M; Shibuya M; Carmeliet P; Soares R; Duda DG; Jain RK; Fukumura D
    Clin Cancer Res; 2016 Jun; 22(12):2993-3004. PubMed ID: 26861455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.
    Crespo-Garcia S; Corkhill C; Roubeix C; Davids AM; Kociok N; Strauss O; Joussen AM; Reichhart N
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):4997-5006. PubMed ID: 28979997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
    Cai J; Ahmad S; Jiang WG; Huang J; Kontos CD; Boulton M; Ahmed A
    Diabetes; 2003 Dec; 52(12):2959-68. PubMed ID: 14633857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.